India’s Pricing Authority Head Shunted Out?
Executive Summary
India’s firebrand pharma pricing authority chief has been transferred out amid sharply polarized views on either side of the debate around his controversial stint.
You may also be interested in...
India’s Top Regulator ‘Relieved Of Post’; Temporary Head In Place
India has appointed a temporary head for its Central Drugs Standard Control Organization, after terminating GN Singh’s position.
India's Device Price Cap Storm Rages On: New Stent Cap And Spotlight On Catheter Trade Margins
India’s medical device pricing storm looks unlikely to abate any time soon, with another round of price caps on stents being enforced. The spotlight is also shining on the sharp variances in trade margins for catheters in the country.
Regulator Warns Of Tougher Pricing Regime In India Amid ‘Market Failure’
India’s apex pricing authority concludes some in Rx industry have not played 'fair'; 25% of products show market failure, Bhupendra Singh says.